Deep diamond AI India Limited has announced the appointment of Mrs. Shashi Kala Dhabriya as Additional Non-Executive Independent Director, effective March 20, 2026. The appointment was formalized through a Board Circular Resolution and disclosed to BSE Limited in compliance with regulatory requirements.

Appointment Details

The Board of Directors approved Mrs. Dhabriya's appointment through a Circular Resolution on March 20, 2026. The appointment has been made in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Profile and Qualifications

Mrs. Shashi Kala Dhabriya brings academic credentials to the board, holding a Master of Arts (M.A.) in History from the University of Rajasthan, which she completed in 1981. The company has confirmed that she is not inter-se related to any other directors currently serving on the board.

Regulatory Compliance

The appointment disclosure was submitted to BSE Limited under the company's scrip code 539559. The notification was made pursuant to Regulation 30 read with Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30, 2026.

Company Background

Deep Health AI India Limited, formerly known as Deep Diamond India Limited, operates with its registered office in Mumbai, Maharashtra, and corporate office in Udaipur, Rajasthan. The company's CIN is L24100MH1994PLC082609, and it was incorporated in 1994. The appointment notification was signed by Managing Director Narayan Singh Rathore (DIN: 10900646).

Deep Health AI India Limited , formerly known as Deep Diamond India Limited, has issued a comprehensive postal ballot notice to shareholders seeking approval for increasing its authorized share capital. The company announced the postal ballot process following its board meeting conducted on February 24, 2026, with remote e-voting scheduled from February 27 to March 28, 2026.

Postal Ballot Notice and E-Voting Schedule

The company dispatched the postal ballot notice on February 26, 2026, to BSE Limited and all registered shareholders through electronic mode. The notice seeks shareholder approval for increasing the authorized share capital through an ordinary resolution.

Authorized Share Capital Enhancement

The primary resolution seeks substantial enhancement of the company's authorized share capital, representing a significant expansion of its financial capacity. This increase requires shareholder approval through the postal ballot process and will involve consequential alteration in the Capital Clause of the Memorandum of Association.

Corporate Restructuring Developments

The postal ballot notice follows the board's earlier approval of the company's registered office relocation from Mumbai to Udaipur, Rajasthan. The relocation was authorized pursuant to Order dated February 09, 2026, received from Regional Director, Western Region, Mumbai.

Regulatory Compliance and Documentation

The postal ballot process complies with Section 108 and 110 of the Companies Act, 2013, and Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company has engaged NSDL for facilitating remote e-voting, with Dr. Ronak Jhuthawat appointed as the scrutinizer for conducting the voting process.

The proposed increase in authorized share capital aims to provide adequate headroom for meeting the company's future business requirements, growth initiatives, and strategic opportunities. The resolution, if approved, will be deemed passed on March 28, 2026, being the last date for e-voting, marking a significant milestone in the company's transformation toward AI and healthcare technology sectors.